All In MedTech

Device Trial Radar · NCT05394662

Safety and Effectiveness of Juveena™ Hydrogel System Following Transcervical Gynecologic Procedures (TCGP) At High-Risk for Intrauterine Adhesions

Safety and Effectiveness of Juveena™ Hydrogel System Following Transcervical Gynecologic Procedures (TCGP) At High-Risk for Intrauterine Adhesions: A Multicenter Randomized Controlled Subject and Evaluator Blinded Pivotal Study

Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingTitle says "pivotal". Randomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

150

Actual

Start

Aug 11, 2022

Primary completion

Apr 23, 2025

Study completion Apr 23, 2025

Sponsor

Lead sponsor
Rejoni Inc.Not on our public-company list
Sponsor type
Industry
First posted
May 27, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is to determine whether intrauterine instillation of Juveena hydrogel following adhesiogenic hysteroscopic procedures (TCGP + Juveena) can safely and effectively reduce the incidence and severity of intrauterine adhesions (IUA) compared to TCGP alone.

Conditions

  • Intrauterine Adhesion

Interventions

  • Juveena Hydrogel SystemDevice

    Application of a novel hydrogel immediately following the transcervical procedure

  • Transcervical Gynecologic Procedures (TCGP)Procedure

    Hysteroscopic adhesiolysis or hysteroscopic myomectomy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Freedom From Intrauterine Adhesions (IUA)Time frame: 8 weeks

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Arizona Gynecology Consultants

    Phoenix, Arizona

  • UCSF Center for Reproductive Health

    San Francisco, California

  • MedStar Washington Hospital Center

    Washington D.C., District of Columbia

12 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.